Summary
Little information has so far been reported regarding the antiproliferative properties of Aconitum alkaloids against human tumor cells despite of their intense toxicities. In the present study, the antitumor properties and radiation sensitizing effects were investigated by various types of novel derivatives prepared from Aconitum alkaloids. The antitumor properties were investigated against human tumor cell lines, A172, A549, HeLa and Raji, respectively, by a cell growth, a clonogenic assay, cell cycle distribution, cell cycle related molecules and γH2AX expression. The novel compounds derived from C20-diterupenoid alkaloids showed a significantly suppressive effect in all cell lines. In contrast, natural C19-norditerpenoid alkaloids and their derivatives showed either no effect or only a slight effect. One of the compounds also showed radiosensitizing properties on A549 cells. These effects are not related to either the cell cycle distribution, the enhancement of apoptosis or the γH2AX expression. Novel derivatives prepared from Aconitum alkaloids, not but natural alkaloids, clearly showed anti-proliferative activity in human tumor cell lines.
Similar content being viewed by others
References
Haveman J, Castro Kreder N, Rodermond HM et al (2004) Cellular response of X-ray sensitive hamster mutant cell lines to gemcitabine, cisplatin and 5-fluorouracil. Oncol Rep 12:187–192
Didelot C, Mirjolet JF, Barberi-Heyob M (2002) Radiation could induce p53-independent and cell cycle-unrelated apoptosis in 5-fluorouracil radiosensitized head and neck carcinoma cells. Can J Physiol Pharmacol 80:638–643
Pauwels B, Korst AE, Andriessen V et al (2005) Unraveling the mechanism of radiosensitization by gemcitabine: the role of TP53. Radiat Res 164:642–650
Zhang M, Boyer M, Rivory L et al (2004) Radiosensitization of vinorelbine and gemcitabine in NCL-H460 non-small-cell lung cancer cells. Int J Radiat Oncol Biol Phys 58:33–60
Baumann M, Krause M (2004) Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results. Radiother Oncol 72:257–266
Kvols LK (2005) Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets. J Nucl Med 46:187S–190S
Sonnemann J, Gekeler V, Ahibrecht K et al (2004) Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel. Cancer Lett 209:177–185
Qing C, Jiang C, Zhang JS et al (2001) Induction of apoptosis in human leukemia K-562 and gastric carcinoma SGC-7901 cells by salvicine, a novel anticancer compound. Anticancer Drugs 12:51–56
Meg LH, Zhang JS, Ding J (2001) Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes. Biochem Pharmacol 62:733–741
Yildiz F, Perez R, Redpath JL (2000) Paclitaxel exposure time determines the nature of interaction with radiation in HeLa cells: the role of apoptosis. Eur J Cancer 36:1426–1532
Chan TY (1994) Aconitine poisoning: a global perspective. Vet Hum Toxicol 36:326–328
Feldkamp A, Koster B, Weber HP (1991) Fatal poisoning caused by aconitine monk's hood (Aconitum napellus). Monatsschr Kinderheilkd 139:366–367
Negulyaev Yu A, Vedernikova EA, Savokhina GA (1990) Aconitine-induced modification of signal sodium channels in neuroblastoma cell membrane. Gen Physiol Biophys Commun 9:167–176
Fu M, Wu M, Wang JF et al (2007) Disruption of the intracellular Ca2+ homeostasis in the cardiac excitation–concentration coupling is a crucial mechanism of arrhythmic toxicity in aconitine-induced cardiomyocytes. Biochem Biophys Res Commun 23:929–936
Wada K, Ishizuki S, Mori T et al (1998) Effects of Aconitum alkaloid kobusine and pseudokobusine derivatives on cutaneous blood flow in mice. Biol Pharm Bull 21:140–146
Wada K, Ishizuki S, Mori T et al (2000) Effects of Aconitum alkaloid kobusine and pseudokobusine derivatives on cutaneous blood flow in mice; II. Biol Pharm Bull 23:607–615
Wada K, Ishizuki S, Mori T et al (1997) Effects of alkaloids from Aconitum yesoense var. macroyesoense on cutaneous blood flow in mice. Biol Pharm Bull 20:978–982
Wada K, Bando H, Amiya T (1985) Two new C20-diterpenoid alkaloids from Aconitum yesoense var. macroyesoense (NAKAI) TAMURA, structures of dehydrolucidusculine and N-deethyldehydrolucidusculine. Heterocycles 23:2473–2477
Bando H, Wada K, Amiya T et al (1987) Studies on Aconitum species V. Constituents of Aconitum yesoense var. macroyesoense (NAKAI) TAMURA. Heterocycles 26:2623–2637
Wada K, Bando H, Amiya T (1988) Studies on Aconitum species VI. Yesoline, a new C20-diterpenoid alkaloid from Aconitum yesoense var. macroyesoense (NAKAI) TAMURA. Heterocycles 27:1249–1252
Wada K, Bando H, Amiya T et al (1989) Studies on Aconitum species. XI. Two new diterpenoid alkaloids from Aconitum yesoense var. macroyesoense (NAKAI) TAMURA V. Heterocycles 29:2141–2148
Wada K, Bando H, Kawahara N (1990) Studies on Aconitum species. XIII. Two new diterpenoid alkaloids from Aconitum yesoense var. macroyesoense (NAKAI) TAMURA VI. Heterocycles 31:1081–1088
Bando H, Kanaiwa Y, Wada K et al (1981) Structure of deoxyjesaconitine. A new diterpene alkaloid from Aconitum subcuneatum NAKAI. Heterocycles 16:1723–1725
Mori T, Bando H, Kanaiwa Y et al (1983) Studies on the constituents of Aconitum Species. II. Structure of deoxyjesaconitine. Chem Pharm Bull 31:2884–2886
Wada K, Bando H, Mori T et al (1985) Studies on the constituents of Aconitum Species. III. On the components of Aconitum subcuneatum NAKAI. Chem Pharm Bull 33:3658–3661
Wada K, Bando H, Watanabe M et al (1985) Studies on the constituents of Aconitum Species. IV. On the components of Aconitum japonicum THUNB. Chem Pharm Bull 33:4717–4722
Bando H, Wada K, Amiya T et al (1988) Studies on the constituents of Aconitum Species. VII. On the components of Aconitum japonicum THUNB. Heterocycles 27:2167–2174
Bando H, Wada K, Tanaka J et al (1989) Two new diterpenoid alkaloids from Delphinium pacific giant and revised 13C-NMR assignment of delpheline. Heterocycles 29:293–1300
Wada K, Yamamoto T, Bando H et al (1992) Four diterpenoid alkaloids from Delphinium elatum. Phytochemistry 31:2135–2138
Jalal Hosseinimehr S, Inanami O, Hamasu T et al (2004) Activation of C-Kit by stem cell factor induces radioresistance to apoptosis through ERK-dependent expression of survivin in HL60 cells. J Radiat Res 45:557–561
Liu Y, Nakahara T, Miyakoshi J et al (2007) Nuclear accumulation and activation of nuclear factor kB after split-dose irradiation in LS174T cells. J Radiat Res 48:13–20
Hall EJ (2000) Radiobiology for the radiologist. Lippincott, Philadelphia
Chodoeva A, Bosc JJ, Guillon J et al (2005) 8-O-Azeloyl-benzoylaconine: a new alkaloid from the roots of Aconitum karacolicum Rapcss and its antiproliferative activities. Bioorg Med Chem 13:6493–6501
Kobayashi J (2004) Molecular mechanism of the recruitment of NBS1/hMRE11/hRAD50 complex to DNA double-strand breaks: NBS1 binds to g-H2AX through FHA/BRCT domain. J Radiat Res 45:473–478
Takahashi A, Ohnishi T (2005) Dose gH2AX foci formation depend on the presence of DNA double strand breaks? Cancer Lett 229:171–179
Acknowledgments
This study was supported by a Grant-in-Aid for Scientific Research Fund from the Ministry of Education, Science and Culture of Japan (No. 19659300, IK).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hazawa, M., Wada, K., Takahashi, K. et al. Suppressive effects of novel derivatives prepared from Aconitum alkaloids on tumor growth. Invest New Drugs 27, 111–119 (2009). https://doi.org/10.1007/s10637-008-9141-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-008-9141-4